Osteoporosis - Recent Advances, New Perspectives and Applications [Working Title]最新文献

筛选

英文中文

Osteoporosis and Dietary Inflammatory Index 骨质疏松症与饮食炎症指数

Osteoporosis - Recent Advances, New Perspectives and Applications [Working Title] Pub Date : 2021-03-31 DOI: 10.5772/INTECHOPEN.96772

O. C. Peloza, S. Žeželj, G. Jovanović, I. Pavičić, Ana Terezija Jerbić Radetić, S. Z. Cvek, Jasna Lulić Drenjak, Gordana Starčević Klasan, A. F. Smojver, Juraj Arbanas

引用次数: 0

Bone Quality of the Dento-Maxillofacial Complex and Osteoporosis. Opportunistic Radiographic Interpretation 牙颌面复合体的骨质量与骨质疏松症。机会性放射学解释

Osteoporosis - Recent Advances, New Perspectives and Applications [Working Title] Pub Date : 2021-03-12 DOI: 10.5772/INTECHOPEN.96487

P. Watanabe, G. A. Rodrigues, M. R. Azenha, M. C. Ribeiro, Enéas de Almeida Souza Filho, Rafael Angelo Soares Vieira, Fábio Santos Bottacin

引用次数: 2

Glucocorticoid-Induced Osteoporosis 激素性骨质疏松症

Osteoporosis - Recent Advances, New Perspectives and Applications [Working Title] Pub Date : 1900-01-01 DOI: 10.5772/intechopen.97416

José Renan Vieira da Costa Júnior, Sérgio Luchini Batista

{"title":"Glucocorticoid-Induced Osteoporosis","authors":"José Renan Vieira da Costa Júnior, Sérgio Luchini Batista","doi":"10.5772/intechopen.97416","DOIUrl":"https://doi.org/10.5772/intechopen.97416","url":null,"abstract":"The use of glucocorticoids (GC) in the medium and long term, causes several considerable side effects, being one of the main ones the reduction of bone mineral density (BMD). Prolonged corticosteroid therapy reduces BMD by up to 20% in trabecular bone and approximately 2–3% in cortical bone in the first year of use. This loss rate declines and stabilizes at approximately 2% in subsequent years. Therefore, there is a considerable increase in the incidence of pathological fractures, whether clinically symptomatic or asymptomatic (detected as a radiological finding), which varies between 30 and 50% of patients who use GC for more than three months. In view of the above, it is essential to prevent fractures and treat osteoporosis in patients using glucocorticoids for long periods (in particular, greater than or equal to 3 months), which may or may not be associated with clinical risk factors or previous fractures. The guidelines for the treatment and prevention of this comorbidity are well established for postmenopausal women and men over 50 years of age. However, for patients below this range, studies are still lacking.","PeriodicalId":182868,"journal":{"name":"Osteoporosis - Recent Advances, New Perspectives and Applications [Working Title]","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129557802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0